PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Clinical trials for PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME trials appear
Sign up with your email to follow new studies for PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a monthly IVIG infusion ease severe OCD in kids with PANS?
Disease control CompletedThis study tested a monthly dose of intravenous immunoglobulin (IVIG) for 6 months in 17 children aged 4–17 with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), a condition marked by sudden, severe OCD or food refusal. Researchers measured changes in symptom severity and …
Matched conditions: PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Phase: PHASE2 • Sponsor: Göteborg University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Hidden costs of PANS: new study reveals financial toll of IVIG treatment
Knowledge-focused CompletedThis completed study surveyed 65 U.S. families to understand the economic and quality-of-life impact of IVIG treatment for PANS/PANDAS. Researchers asked about medical visits, insurance, work absences, and children's school attendance. The goal is to shed light on the hidden cost…
Matched conditions: PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:31 UTC